Literature DB >> 26492905

Determination of a safe INR for joint injections in patients taking warfarin.

M A Bashir1, R Ray1, P Sarda1, S Li1, S Corbett1.   

Abstract

INTRODUCTION: With an increase in life expectancy in 'developed' countries, the number of elderly patients receiving joint injections for arthritis is increasing. There are legitimate concerns about an increased risk of thromboembolism if anticoagulation is stopped or reversed for such an injection. Despite being a common dilemma, the literature on this issue is scarce.
METHODS: We undertook 2,084 joint injections of the knee and shoulder in 1,714 patients between August 2008 and December 2013. Within this cohort, we noted 41 patients who were taking warfarin and followed them immediately after joint injection in the clinic or radiology department, looking carefully for complications. Then, we sought clinical follow-up, correspondence, and imaging evidence for 4 weeks, looking for complications from these joint injections. We recorded International Normalised Ratio (INR) values before injection.
RESULTS: No complications were associated with the procedure after any joint injection. The radiologists who undertook ultrasound-guided injections to shoulders re-scanned the joints looking for haemarthroses: they found none. A similar outcome was noted clinically after injections in the outpatient setting.
CONCLUSION: With a mean INR of 2.77 (range, 1.7-5.5) and a maximum INR within this group of 5.5, joint injections to the shoulder and knee can be undertaken safely in primary or secondary care settings despite the patient taking warfarin.

Entities:  

Keywords:  Complications; Injection; International Normalised Ratio; Warfarin

Mesh:

Substances:

Year:  2015        PMID: 26492905      PMCID: PMC5096611          DOI: 10.1308/rcsann.2015.0044

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  11 in total

1.  [Frequency of the bleeding risk in patients receiving warfarin submitted to arthrocentesis of the knee].

Authors:  G Salvati; L Punzi; M Pianon; C Valvason; F Schiavon; N Noal; S Todesco
Journal:  Reumatismo       Date:  2003

2.  Safety of arthrocentesis and joint injection in patients receiving anticoagulation at therapeutic levels.

Authors:  Imdad Ahmed; Elie Gertner
Journal:  Am J Med       Date:  2012-03       Impact factor: 4.965

3.  Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.

Authors:  Imdad Ahmed; Elie Gertner; William B Nelson; Chad M House; Ranjan Dahiya; Christopher P Anderson; David G Benditt; Dennis W X Zhu
Journal:  Heart Rhythm       Date:  2010-02-20       Impact factor: 6.343

4.  A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium.

Authors:  J Thumboo; J D O'Duffy
Journal:  Arthritis Rheum       Date:  1998-04

5.  Warfarin management in patients on continuous anticoagulation therapy undergoing total knee replacement.

Authors:  R Chana; L Salmon; A Waller; L Pinczewski
Journal:  J Bone Joint Surg Br       Date:  2011-11

6.  Radial versus femoral access for orally anticoagulated patients.

Authors:  Antonios G Ziakas; Konstantinos C Koskinas; Stavros Gavrilidis; George D Giannoglou; Stavros Hadjimiltiades; Ioannis Gourassas; Efstratios Theofilogiannakos; Fotios Economou; Ioannis Styliadis
Journal:  Catheter Cardiovasc Interv       Date:  2010-10-01       Impact factor: 2.692

7.  Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment.

Authors:  Antti-Pekka Annala; Pasi P Karjalainen; Pekka Porela; Kai Nyman; Antti Ylitalo; K E Juhani Airaksinen
Journal:  Am J Cardiol       Date:  2008-05-22       Impact factor: 2.778

8.  Warfarin prevalence, indications for use and haemorrhagic events.

Authors:  W Ouirke; M Cahill; K Perera; J Sargent; J Conway
Journal:  Ir Med J       Date:  2007-03

9.  Discontinuation of warfarin is unnecessary in total knee arthroplasty.

Authors:  David A Rhodes; Erik P Severson; Jeffrey T Hodrick; Harold K Dunn; Aaron A Hofmann
Journal:  Clin Orthop Relat Res       Date:  2010-01       Impact factor: 4.176

Review 10.  Current concepts of the management of dental extractions for patients taking warfarin.

Authors:  G Carter; A N Goss; J Lloyd; R Tocchetti
Journal:  Aust Dent J       Date:  2003-06       Impact factor: 2.291

View more
  5 in total

1.  Hand Corticosteroid Injections in Patients on "Blood Thinners".

Authors:  Ajith Malige; Kristofer S Matullo
Journal:  Hand (N Y)       Date:  2019-03-17

Review 2.  Intraarticular Corticosteroids for Hip Osteoarthritis: A Review.

Authors:  Magda Choueiri; Xavier Chevalier; Florent Eymard
Journal:  Cartilage       Date:  2020-08-20       Impact factor: 3.117

3.  Management of Haemarthrosis in Patients On Oral Anticoagulants.

Authors:  James Dalrymple; Andrew Davies; Alexandra Biggs; Shahil Rajcoomar; Ian Gill
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-05-11

4.  The EANM guideline for radiosynoviorthesis.

Authors:  W U Kampen; B Boddenberg-Pätzold; M Fischer; M Gabriel; R Klett; M Konijnenberg; E Kresnik; H Lellouche; F Paycha; L Terslev; C Turkmen; F van der Zant; L Antunovic; E Panagiotidis; G Gnanasegaran; T Kuwert; T Van den Wyngaert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-20       Impact factor: 9.236

Review 5.  Implications of apixaban for dental treatments.

Authors:  Adrian Curto; Alberto Albaladejo
Journal:  J Clin Exp Dent       Date:  2016-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.